Dr. Anne Peters is one of our favorite endocrinologists in the limelight. She’s director of the Diabetes Program at the University of Southern California (USC), head of the nation’s largest outreach program for community-based diabetes prevention and treatment in Los Angeles, and author of the best-selling book Conquering Diabetes. She does a series of regular videos on diabetes for Medscape and other sites, and we’ve interviewed her and featured her here several times in the…Read more »
Sixteen-thousand doctors, scientists, and other healthcare providers. Hundreds of Pharma industry folks and food and diabetes supply vendors manning 171 booths in a cavernous exhibit hall. Over 2,500 research reports, plus over 2,000 more studies presented on mini-billboards known as research posters. More than 150 live sessions where experts present nearly 378 reports on every imaginable aspect of diabetes in the human body.
This is the American Diabetes Association annual Scientific Sessions conference, taking place…
It’s not too often we have a new insulin making its way on the scene, so we were excited to hear that Novo Nordisk filed two applications with the FDA for a new “ultra long acting” insulin called Degludec, and another for something called DegludecPlus, a combination of degludec and insulin aspart (Novolog), which would be available in an insulin pen in a fixed 70% degludec/30% Novolog ratio. The company is hoping for FDA approval…Read more »